Register to get unlimited access to Citywire’s fund manager database. Registration is free and only takes a minute.

SVM World Equity

Ranked 494 out of 663 in - Global over 12 months
All calculations are in GBP unless stated

Managed by

Neil Veitch

Neil Veitch holds a BA degree in economics and an MSc in investment management. He is currently a fund manager at SVM where his sector responsibilities include European industrials, technology, oil and gas and UK support services and house builders. Prior to this he was responsible for UK mid and small cap investments at Kempen Capital Management, a Dutch merchant bank. He has over 11 years' experience in investment management and is a qualified Chartered Financial Analyst.


To achieve above average capital growth over the medium to long term (although short-term investment opportunities will also be considered) and it aims to outperform its peers in the IMA Global Growth Sector. The Fund will invest in a portfolio of global equities and other equity related instruments such as Exchange Traded Funds.

Showing fund performance in United Kingdom View performance globally


Global over : 28/02/2017 - 28/02/2018

Total Return

Quarterly Performance

to 01/01/2018 Annual Q1 Q2 Q3 Q4
2017 12.0% 2.8% 2.6% 1.2% 4.9%
2016 21.1% -2.3% 1.9% 9.7% 10.9%
2015 7.3% 8.6% -1.7% -8.2% 9.4%
2014 5.1% 1.7% 0.2% 1.9% 1.2%
2013 24.5% 16.3% 2.7% 0.9% 3.4%
2012 21.4% 12.1% -2.9% 8.0% 3.3%
2011 -13.6% -0.4% -1.3% -14.7% 2.9%
2010 16.6% 6.7% -11.1% 13.6% 8.1%
2009 31.4% -12.1% 14.8% 30.3% -0.1%
2008 -32.0% -10.9% -1.5% -19.7% -3.5%
2007 7.9% 4.3% 4.2% 1.8% -2.6%
2006 25.3% 12.8% -5.9% 5.6% 11.8%
2005 7.7%

Month by Month Performance

Returns Vs Risk

Registered For Sale In

  1. United Kingdom

Fund Info

  • Launch date01/12/2010
  • Share Class size02Mn
  • Base currencyGBP

Purchase Info

  • Min. initial investment1,000
  • Min. regular additional investment0


  • Annual management1.50%
  • Initial investment1.5

Related News

Have AstraZeneca's shareholders blown it?

Following the rejection of the mixed cash and equity offer, shares in AstraZeneca dipped 11% on Monday as investors grew sceptical.

SVM's Veitch: two UK housebuilders still offering value

Neil Veitch, a Citywire + rated equities manager at SVM, shares his expectations for the world’s stock markets with Wealth Manager.

A-rated Veitch: a trio of global picks for a risky environment

After a decent performance run, SVM's Citywire A-rated Neil Veitch looks ahead to next year and highlights three of his best ideas in this exclusive article for Wealth Manager.  

How this wealth manager is navigating QE-driven bubbles

IBoss managing director Chris Metcalfe is cautious of asset prices fuelled by quantitative easing (QE). He favours underlying managers with a pragmatic and flexible approach, particularly in IBoss’s fixed income and UK and global equity exposure.

SVM co-founder Donald Robertson exits

SVM Asset Management’s co-founder Donald Robertson has resigned from the firm, leaving fellow co-founder Colin McLean managing a range of funds.

SVM to convert UK Alpha fund into global equity fund for Veitch

SVM is planning to convert Colin McLean's SVM UK Alpha fund into a new fund which can capitalise on global equity opportunities.

Behavioural Finance: Colin McLean on how to exploit a sell off

Colin McLean, managing director of SVM Asset Management, on why during market sell offs investors ought to be thinking about the impact of behavioural finance.

Investment Line: The bear case for gold

With both the inflationists and deflationists backing gold, some managers are starting to get nervous that very few are factoring in a negative scenario for the precious metal.

Investment Line: Hedge funds could spark Cadbury sell off

Merger arbitrage funds increasing their stake in the firm ups the risk of a share price crash if Kraft deal falls through.

Fund Results: The Citywire verdict on who's hot and who's not

This week with Ecclesiastical Higher Income, SVM UK Alpha, JPM New Europe and Cazenove UK Opportunities


Performance is for the period shown (month end to month end, bid/bid, gross income reinvested, calculated in the currency and currencies indicated).